BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17164778)

  • 1. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
    Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
    Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of simian/human immunodeficiency virus replication in CD4+ T cells derived from lentiviral-transduced CD34+ hematopoietic cells.
    Braun SE; Wong FE; Connole M; Qiu G; Lee L; Gillis J; Lu X; Humeau L; Slepushkin V; Binder GK; Dropulic B; Johnson RP
    Mol Ther; 2005 Dec; 12(6):1157-67. PubMed ID: 16168713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
    Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
    J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of human CD34+ hematopoietic progenitor cells by a retroviral vector expressing an RRE decoy inhibits human immunodeficiency virus type 1 replication in myelomonocytic cells produced in long-term culture.
    Bahner I; Kearns K; Hao QL; Smogorzewska EM; Kohn DB
    J Virol; 1996 Jul; 70(7):4352-60. PubMed ID: 8676458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of simian immunodeficiency virus (SIV) replication by an SIV-based lentiviral vector expressing antisense Env.
    Braun SE; Lu XV; Wong FE; Connole M; Qiu G; Chen Z; Slepushkina T; Slepushkin V; Humeau LM; Dropulic B; Johnson RP
    Hum Gene Ther; 2007 Jul; 18(7):653-64. PubMed ID: 17600461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critical factors influencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors.
    Haas DL; Case SS; Crooks GM; Kohn DB
    Mol Ther; 2000 Jul; 2(1):71-80. PubMed ID: 10899830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
    Di Nunzio F; Piovani B; Cosset FL; Mavilio F; Stornaiuolo A
    Hum Gene Ther; 2007 Sep; 18(9):811-20. PubMed ID: 17824830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rev-independent expression of synthetic gag-pol genes of human immunodeficiency virus type 1 and simian immunodeficiency virus: implications for the safety of lentiviral vectors.
    Wagner R; Graf M; Bieler K; Wolf H; Grunwald T; Foley P; Uberla K
    Hum Gene Ther; 2000 Nov; 11(17):2403-13. PubMed ID: 11096444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of lentiviral vectors for transducing cells from the central nervous system.
    Li M; Husic N; Lin Y; Snider BJ
    J Vis Exp; 2012 May; (63):e4031. PubMed ID: 22664962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
    Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
    Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
    Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
    Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
    Mautino MR; Morgan RA
    Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human immunodeficiency virus-1 (HIV-1) replication after transduction of granulocyte colony-stimulating factor-mobilized CD34+ cells from HIV-1-infected donors using retroviral vectors containing anti-HIV-1 genes.
    Bauer G; Valdez P; Kearns K; Bahner I; Wen SF; Zaia JA; Kohn DB
    Blood; 1997 Apr; 89(7):2259-67. PubMed ID: 9116267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
    Ramezani A; Hawley TS; Hawley RG
    Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
    Sirven A; Ravet E; Charneau P; Zennou V; Coulombel L; Guétard D; Pflumio F; Dubart-Kupperschmitt A
    Mol Ther; 2001 Apr; 3(4):438-48. PubMed ID: 11319904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Demaison C; Parsley K; Brouns G; Scherr M; Battmer K; Kinnon C; Grez M; Thrasher AJ
    Hum Gene Ther; 2002 May; 13(7):803-13. PubMed ID: 11975847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an Rev-independent, minimal simian immunodeficiency virus-derived vector system.
    Pandya S; Boris-Lawrie K; Leung NJ; Akkina R; Planelles V
    Hum Gene Ther; 2001 May; 12(7):847-57. PubMed ID: 11339901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.